Evidence map›Paper›PMID 26392023›Full record

ArticleBurns : journal of the International Society for Burn Injuries2015

Topically applied metal chelator reduces thermal injury progression in a rat model of brass comb burn.

Cheng Z Wang, Amina El Ayadi, Juhi Goswamy, Celeste C Finnerty, Randy Mifflin, Linda Sousse, Perenlei Enkhbaatar, John Papaconstantinou, David N Herndon, Naseem H Ansari

Abstract read
In one paragraph

Article in Burns : journal of the International Society for Burn Injuries, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Cheng Z WangDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0647, United States.
Amina El AyadiDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0647, United States; Shriners Hospital for Children, Galveston, TX, United States.
Juhi GoswamyUniversity of Miami Miller School of Medicine, Miami, FL 33124, United States.
Celeste C FinnertyDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0647, United States; Institute for Translational Sciences, Galveston, TX, United States; Shriners Hospital for Children, Galveston, TX, United States.
Randy MifflinDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0647, United States; Shriners Hospital for Children, Galveston, TX, United States.
Linda SousseDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0647, United States; Shriners Hospital for Children, Galveston, TX, United States.
Perenlei EnkhbaatarDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555-0647, United States.
John PapaconstantinouDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0647, United States.
David N HerndonDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0647, United States; Shriners Hospital for Children, Galveston, TX, United States.
Naseem H AnsariDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0647, United States. Electronic address: nansari@utmb.edu.
The University of Texas Medical Branch at Galveston · USShriners Hospitals for Children - Galveston · USUniversity of Miami · US

Funding

Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Localized Metal Modulation as a First Line Treatment of Burn InjuriesR43AR062419 · NIAMS · LIVIONEX, INC. · PI GIN, JERRY · 2012 to 2012
$297k
NIAMS NIH HHS R43 AR062419NIEHS NIH HHS P30 ES006676
6 · The paper itself

Abstract

unlabelledOxidative stress may be involved in the cellular damage and tissue destruction as burn wounds continues to progress after abatement of the initial insult. Since iron and calcium ions play key roles in oxidative stress, this study tested whether topical application of Livionex formulation (LF) lotion, that contains disodium EDTA as a metal chelator and methyl sulfonyl methane (MSM) as a permeability enhancer, would prevent or reduce burns.

methodsWe used an established brass comb burn model with some modifications. Topical application of LF lotion was started 5 min post-burn, and repeated every 8 h for 3 consecutive days. Rats were euthanized and skin harvested for histochemistry and immunohistochemistry. Formation of protein adducts of 4-hydroxynonenal (HNE), malonadialdehyde (MDA) and acrolein (ACR) and expression of aldehyde dehydrogenase (ALDH) isozymes, ALDH1 and ALDH2 were assessed.

resultsLF lotion-treated burn sites and interspaces showed mild morphological improvement compared to untreated burn sites. Furthermore, the lotion significantly decreased the immunostaining of lipid aldehyde-protein adducts including protein -HNE, -MDA and -ACR adducts, and restored the expression of aldehyde dehydrogenase isozymes in the unburned interspaces.

conclusionThis data, for the first time, demonstrates that a topically applied EDTA-containing lotion protects burns progression with a concomitant decrease in the accumulation of reactive lipid aldehydes and protection of aldehyde dehydrogenase isozymes. Present studies are suggestive of therapeutic intervention of burns by this novel lotion.

Indexed as

BurnsAcroleinAdministration, CutaneousAldehyde DehydrogenaseAldehyde Dehydrogenase 1 FamilyAldehyde Dehydrogenase, MitochondrialAldehydesAnimalsChelating AgentsCopperDimethyl SulfoxideDisease Models, AnimalEdetic AcidImmunohistochemistryMalondialdehydeMitochondrial Proteins4-hydroxy-2-nonenalAcroleinAldehyde DehydrogenaseAldehyde Dehydrogenase 1 FamilyAldehyde Dehydrogenase, MitochondrialAldehydesAldh1a1 protein, ratAldh2 protein, ratbrassChelating AgentsCopperdimethyl sulfoneDimethyl SulfoxideEdetic AcidMalondialdehydeMitochondrial ProteinsRetinal DehydrogenaseSulfonesZincBrass comb burnBurn progressionIron chelationOxidative stressReactive aldehydesThermal injuryWound healing

Identifiers

PMID26392023
PMCPMC4943083
OpenAlexW1751829753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.